Use Of Cholesterol Drugs By Patients Without High Cholesterol Level

Use Of Cholesterol Drugs By Patients Without High Cholesterol Level.


When the US Food and Drug Administration in February 2010 approved the use of the cholesterol-lowering statin downer Crestor for some mortals with well-adjusted cholesterol levels, cardiologist Dr Steven E Nissen cheered the decision. "You have to go with the systematic evidence," said Nissen, who is chairman of cardiovascular cure-all at the Cleveland Clinic order Glucolo. "A clinical woe was done and there was a massive reduction in morbidity and mortality in population treated with this drug".



But Dr Mark A Hlatky, a professor of healthfulness investigation and procedure and c physic at Stanford University, has expressed doubts about the FDA move. He worries that more ladies and gentlemen will rely on a pastille rather than slim and use to cut their heart risk, and also points to studies linking statins such as Crestor to muscle troubles and even diabetes. "I haven't seen anything that changes my attend about that," Hlatky said.



So, will millions of fine fettle Americans soon sign the millions of less-than-healthy mobile vulgus who already stick these blockbuster drugs? The FDA's Feb 9 confirmation of expanded use of rosuvastatin (Crestor) was based on results of the JUPITER study, which active more than 18000 commonality and was financed by the drug's maker, AstraZeneca. People in the nuisance who took the narcotic for an average of 1,9 years had a 44 percent crop peril of heart attack, stroke and other cardiovascular problems compared to those who took a placebo - results so extraordinary that the pest was cut short. Based on JUPITER, an FDA consultative committee voted 12 to 4 in December to favour widened use of the drug.



The individuals in the trial included men over 50 and women over 60 with routine or near-normal cholesterol levels. However, these individuals did have dear levels of C-reactive protein, a marker of infection that has also been linked to cardiovascular problems. They also had at least one other love chance factor, such as obesity or heinous blood pressure.



For that specific group, Crestor makes sense, Nissen said. "Over a five-year age of time, you mitigate one liquidation or minor stroke for every 25 people treated," he noted. Whether or not others with natural cholesterol should abide Crestor or another statin remains unclear. "Not Dick with normal cholesterol should be treated," Nissen said. "You should give it to settle with a excessive enough risk".